Annual Report for the Financial Year 2024-25 along with Notice of 38th Annual General Meeting (AGM)
BI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bilcare Limited has submitted its Annual Report for FY 2024-25 and the Notice of its 38th AGM, scheduled for September 24, 2025 at 12:00 Noon via Video Conference. On a standalone basis, revenue from operations (including other income) rose to Rs. 32.96 crore from Rs. 26.18 crore, and profit before tax stood at Rs. 5.45 crore versus Rs. 5.70 crore in the prior year, with EPS of Rs. 1.70. On a consolidated basis, revenue grew to Rs. 806.50 crore from Rs. 769.70 crore, but the company reported a net loss of Rs. 56.18 crore, though narrower than Rs. 58.54 crore in FY24. The Board has not recommended any dividend. Key updates include a change in statutory auditor (Sharp & Tannan resigned, Patki & Soman appointed), pending SFIO investigation (sub-judice), outstanding public fixed deposits of Rs. 49.49 crore, and the sale of leasehold land at Patalganga for Rs. 3.25 crore.
Standalone profitability remains stable with revenue growth, but consolidated losses persist, signaling continued pressure at the group/subsidiary level. The SEBI penalty paid under protest, ongoing SFIO matter, and director resignations may keep the stock under cautious watch. No dividend is a negative for income-focused shareholders.